Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies - Additional Information (Details)

v3.24.3
Basis of Presentation and Significant Accounting Policies - Additional Information (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Summary Of Significant Accounting Policies [Line Items]          
Revenue $ 0   $ 0    
Research and Development Expense 4,189,873   $ 10,016,982    
Minimum | Office Equipment          
Summary Of Significant Accounting Policies [Line Items]          
Estimated Useful Lives     three    
Maximum | Office Equipment          
Summary Of Significant Accounting Policies [Line Items]          
Estimated Useful Lives     five    
Vendor [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Research and Development Expense $ 149,000 $ 19,000 $ 446,000 $ 30,000  
Payable balance to vendor     $ 74,000   $ 57,000
Customer Concentration Risk | Sales Revenue          
Summary Of Significant Accounting Policies [Line Items]          
Concentration risk, percentage   100.00%   100.00%